1. Metropolis Healthcare
stock logo

56% Buy

Metropolis Healthcare Share Price

METROPOLIS

₹2,132.00-₹9.60 (-0.45%) TodayLast updated on 02 Dec, 2024 | 15:16 IST

Metropolis Healthcare Share Price Chart

Please wait...
  • About Metropolis Healthcare
  • Fundamentals
  • Events
  • F&O (Option chain)
  • More
  • News

About Metropolis Healthcare

Metropolis Healthcare Financials

arrow
Market cap
Market Cap Switch₹10,979 Crs
Open
₹2,134.85
Close
₹2,141.60
Circuit range
₹2,355.75 - ₹1,927.45
Day range
₹2,128.10 - ₹2,187.65
Year range
₹1,450.00 - ₹2,318.30
Volume
60,141
Avg. traded
₹2,159.77
Revenue (12m)
₹1,285 Crs
Metropolis Healthcare

Engaged in diagnostic services, Metropolis Healthcare Limited offers a range of clinical laboratory tests and profiles used for early detection, confirmation and monitoring of disease. It also offers analytical and support services to clinical research organisations for their clinical research projects. The company’s services include pathology testing services, corporate wellness, clinical research services and labs in hospitals. Metropolis Healthcare owns diagnostic centres in the Middle East, South Asia and Africa along with its network in India spread across more than 220 cities.

Metropolis has invested in a variety of specialised tests and several advanced tests and technologies introduced in the global market. The company has nearly 2800 specialised tests.

Business operations

Metropolis Healthcare was started in 1980 as a single diagnostic laboratory in Mumbai by Dr Sushil Kanubhai Shah. The company became a public entity in 2006 and was renamed Metropolis Health Services (India) Limited. The company established its first referral laboratory in 1981. Metropolis started clinical research services in 1992. Ameera Sushil Shah joined the team of Metropolis as one of the partners in the company in 1998. She played a major role in the company's growth strategy and was key to its expansion. In 2001, the company completed its first major acquisition and took over the business of Sudharma, Kerala, in 2001. The same year the company introduced its home service vertical.

In 2006, Metropolis received capital funding from ICICI Ventures. The company executed a secondary transaction by Foxcreek Investment Limited, an affiliate company of Warburg Pincus. The company sets its foot outside the Indian market, taking its services to developing African countries. In 2015, Warburg Pincus exited the company, giving the promoters management control of the firm.

The company inducted a new professional team and rolled out the Metropolis retail strategy in 2016.

In 2019-20, was a year of growth for the company as it pushed for retail expansion. Metropolis also initiated its first public-private partnership (PPP). The company launched its initial public offering (IPO) and was listed on the Indian stock markets.

In 2021-22, the company acquired Hitech Diagnostics Centre to boost its presence in the South Indian markets. It also initiated a network expansion project (90:30) with 90 labs and 1,800 service collection centres in tier 2 and tier 3 cities across India. Metropolis absorbed 8 wholly-owned subsidiaries into the company.

It also became the industry’s first firm to introduce an Employee Value Proposition (EVO). The company rolled out the Metropolis 3.0 strategy to expand its consumer reach via a direct-to-consumer model.

As of January 10, 2024, the company’s market capitalisation is valued at over ₹ 8,200 crores. Metropolis Healthcare’s share price has slipped by over 23% in the last three years.

Financial highlights

⦁ Metropolis Healthcare’s total revenue from operations in FY23 stood at ₹1148. 2 crores, recording a dip of 10.86% from ₹1228.34 crores in the last financial year. ⦁ The company reported a net profit of ₹143.4 crore in FY23 as against ₹215 crore in FY22. ⦁ The EBITDA stood at ₹293 crore in FY23, as compared to ₹349 crore in the previous financial year, recording a decline of 16%. ⦁ Its basic earnings per share (EPS) slipped to ₹27.91 in FY23 from ₹41.87 in the last financial year.

Metropolis Healthcare Key indicators

arrow
52 week high
₹2,318.30
52 week low
₹1,450.00
P/E ratio
74.44
P/B ratio
9.28
ROE
11.87%
ROCE
18.02%
Dividend yield
0.19%
Debt/Equity ratio
EPS
22.62

Learn more

Investment checklist: (3/6)
arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

56%

Hold

6%

Sell

38%

This analysis is based on the reviews of 16 experts in the last 7 days

Metropolis Healthcare Fundamentals

Metropolis Healthcare Financial Ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

24.96%

Net profit margin

10.5%

ROE

11.87%

ROA

7.32%

ROCE

18.02%

Learn more

Metropolis Healthcare Shareholder returns

arrow
1 day
+0.08%
1 week
+3.87%
1 month
+1.06%
3 months
+3.02%
1 year
+26.72%
3 years
-31.59%
5 years
+53.55%

Revenue statement

All values are in ₹ Crores (Cr)
arrow
  • Revenue

  • Operating profit

  • Net profit

Learn more

Cash flow

All values are in ₹ Crores (Cr)
arrow
  • Operating

  • Investing

  • Financing

Learn more

Balance sheet

All values are in ₹ Crores (Cr)
arrow

Total assets

Total liabilities

Learn more

Metropolis Healthcare Share Price history

arrow
DayOpenCloseChange %
Fri, Nov 29 2024
₹2,130.95
₹2,141.60
+0.08%
Thu, Nov 28 2024
₹2,175.00
₹2,139.85
-1.30%
Wed, Nov 27 2024
₹2,153.95
₹2,168.00
+0.47%
Tue, Nov 26 2024
₹2,113.00
₹2,157.95
+1.88%
Mon, Nov 25 2024
₹2,068.00
₹2,118.10
+2.73%
Fri, Nov 22 2024
₹2,010.00
₹2,061.85
+2.29%
Thu, Nov 21 2024
₹2,007.80
₹2,015.75
-0.24%
Tue, Nov 19 2024
₹2,025.70
₹2,020.70
-0.02%

Metropolis Healthcare Shareholding Pattern

arrow

Promoters (49.43%)

Mutual Funds (24.33%)

Retail and other (3.99%)

Foreign institutions-FII (18.56%)

Other domestic institutions (3.69%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹4/share

    Ex date 17 Nov 2023

    expand tab
  • Dividend • ₹8/share

    Ex date 23 Feb 2023

    expand tab
  • Dividend • ₹8/share

    Ex date 21 Feb 2022

    expand tab

Learn more

FAQs on Metropolis Healthcare

What is the Metropolis Healthcare share price today?

chevron-up
Metropolis Healthcare share price is ₹ 2,132.00 today.

What is today’s high & low share price of Metropolis Healthcare?

chevron-up
Metropolis Healthcare share price high: ₹ 2,187.65 and low: ₹ 2,128.10

What is the Metropolis Healthcare share price high and low in the last 52 weeks on the NSE?

chevron-up
52 Week share High Price is ₹ 2,318.30 and Low Price is ₹ 1,450.00

What is the Metropolis Healthcare Stock Symbol?

chevron-up
The Metropolis Healthcare Stock symbol is METROPOLIS.

Can I buy Metropolis Healthcare shares on Holidays?

chevron-up
No, shares of Metropolis Healthcare or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Metropolis Healthcare shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.